CHRONIC LOW-GRAD INFLAMMATION, VASCULAR ENDOTHELIAL FUNCTION AND INSULIN SENSITI
慢性低度炎症、血管内皮功能和胰岛素敏感性
基本信息
- 批准号:7604513
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgeBlood GlucoseBlood PressureBlood VesselsCardiovascular systemCellsCentral obesityCholesterolChronicClinicalComputer Retrieval of Information on Scientific Projects DatabaseContractsFunctional disorderFundingGlucoseGrantHeart DiseasesHormonesHumanIndividualInflammationInstitutionInsulinInsulin ResistanceLipidsLipoproteinsMetabolic DiseasesMetabolic syndromeMetabolismMolecularObesityOxidative StressPhysical activityPlasmaProcessReactive Oxygen SpeciesResearchResearch PersonnelResourcesRisk FactorsSourceStimulusTestingUnited States National Institutes of Healthimprovedneuronal cell bodypreventresponsevascular inflammation
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Metabolic syndrome is a clustering of risk factors for heart disease. Blood vessels should dilate or contract in response to different stimuli, such as increased blood pressure, to prevent drastic changes in blood pressure. When the blood vessels do not function properly this is usually the result of endothelial dysfunction. Insulin is a hormone that converts blood sugar, or glucose, into useable energy. Insulin resistance occurs when the body no longer has the ability to produce or release the right amount of insulin. Endothelial dysfunction and insulin resistance are two key components of the metabolic syndrome. Increases in age, total and abdominal obesity, physical inactivity, cholesterol, and blood pressure are generally associated with endothelial dysfunction and insulin resistance. Importantly, we know that inflammation and oxidative stress are associated with endothelial function and insulin resistance. Oxidative stress is the exposure of the body's cells to molecules (i.e. reactive oxygen species) that are generated continuously in the body as a function of normal metabolism. Reactive oxygen species can produce damage to cells and interfere with the body's normal function, such as the ability of blood vessels to dilate or produce insulin. In humans we are unable to block oxidative stress, but we can block inflammation. Accordingly, the proposed research will test the hypothesis that inhibition of inflammation may improve endothelial dysfunction and insulin resistance in individuals varying in age, adiposity, habitual physical activity levels, plasma lipids and lipoproteins, and/or blood pressure, but without clinical cardiovascular or metabolic diseases. Furthermore, the proposed research will determine the molecular mechanisms involved in these processes.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
代谢综合征是心脏病危险因素的聚类。 血管应响应不同的刺激(例如升高血压)来扩张或收缩,以防止血压的急剧变化。 当血管无法正常工作时,这通常是内皮功能障碍的结果。 胰岛素是一种将血糖或葡萄糖转化为可用能量的激素。 当人体不再具有产生或释放适量的胰岛素的能力时,就会发生胰岛素抵抗。 内皮功能障碍和胰岛素抵抗是代谢综合征的两个关键组成部分。 年龄,腹部肥胖,身体不活跃,胆固醇和血压的增加通常与内皮功能障碍和胰岛素抵抗有关。 重要的是,我们知道炎症和氧化应激与内皮功能和胰岛素抵抗有关。 氧化应激是人体细胞暴露于分子(即活性氧),这些分子是在体内连续产生的,这是正常代谢的函数。 活性氧可能会对细胞产生损害并干扰人体的正常功能,例如血管扩张或产生胰岛素的能力。 在人类中,我们无法阻止氧化应激,但我们可以阻止炎症。 因此,拟议的研究将检验以下假设:抑制炎症可能会改善年龄,肥胖,习惯性体育活动水平,血浆脂质和/或血压的人的内皮功能障碍和胰岛素抵抗,但没有临床心血管或代谢疾病。 此外,提出的研究将确定这些过程中涉及的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA LIESNEWSKI其他文献
LISA LIESNEWSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA LIESNEWSKI', 18)}}的其他基金
CHRONIC LOW-GRAD INFLAMMATION, VASCULAR ENDOTHELIAL FUNCTION AND INSULIN SENSITI
慢性低度炎症、血管内皮功能和胰岛素敏感性
- 批准号:
7719556 - 财政年份:2008
- 资助金额:
$ 1.92万 - 项目类别:
相似国自然基金
我国60岁以上人群血压、血糖和血胆固醇水平综合管理的优化区间:临床结局驱动的“三高共管”一级预防干预目标研究
- 批准号:72274133
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
心肌细胞膜受体失衡在高血压合并高血糖微环境下心肌重构发生发展中的作用和干预研究
- 批准号:82230009
- 批准年份:2022
- 资助金额:261 万元
- 项目类别:重点项目
肾小管上皮细胞钠-葡萄糖共转运体2(SGLT2)-环氧-二十碳-三烯酸(EETs)调节血糖代谢和血压的新靶点
- 批准号:81873512
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
胰高血糖素样肽-1保护高血压血管内皮功能的线粒体机制
- 批准号:81873475
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
肾素-血管紧张素-醛固酮系统对高血压并发糖尿病的作用分析
- 批准号:81000110
- 批准年份:2010
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health
产后强化抗高血压治疗可改善女性心血管健康
- 批准号:
10664483 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Food Security and Cardiovascular and Metabolic Health
粮食安全与心血管和代谢健康
- 批准号:
10735838 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
- 批准号:
10724050 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Feasibility of Improving Glycemia to Prevent Alzheimer's Disease
改善血糖预防阿尔茨海默病的可行性
- 批准号:
10633688 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别: